Erlotinib Recruiting Phase 2 Trials for Diffuse Intrinsic Pontine Glioma (DIPG) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02233049Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication